ASX Penny Stocks To Watch In January 2025

The Australian market recently experienced a slight downturn, with the ASX200 closing down 0.61% at 8,378 points, despite a surge in tech stocks on Wall Street. As investors anticipate Australia's upcoming quarterly inflation report and potential interest rate changes, attention turns to smaller investment opportunities that might weather these fluctuations. Penny stocks—though an older term—still capture the essence of investing in smaller or emerging companies that can offer substantial value when backed by strong financials and growth potential.

Top 10 Penny Stocks In Australia

Name	Share Price	Market Cap	Financial Health Rating
Embark Early Education (ASX:EVO)	A$0.76	A$141.28M	★★★★☆☆
LaserBond (ASX:LBL)	A$0.59	A$68.57M	★★★★★★
SHAPE Australia (ASX:SHA)	A$2.92	A$243.76M	★★★★★★
Austin Engineering (ASX:ANG)	A$0.50	A$325.58M	★★★★★☆
Helloworld Travel (ASX:HLO)	A$1.97	A$322.38M	★★★★★★
MaxiPARTS (ASX:MXI)	A$1.93	A$107.31M	★★★★★★
GTN (ASX:GTN)	A$0.5425	A$108.99M	★★★★★★
IVE Group (ASX:IGL)	A$2.15	A$333.01M	★★★★☆☆
Servcorp (ASX:SRV)	A$4.99	A$488.43M	★★★★☆☆
SKS Technologies Group (ASX:SKS)	A$1.59	A$247.67M	★★★★★★

Click here to see the full list of 1,026 stocks from our ASX Penny Stocks screener.

Let's dive into some prime choices out of the screener.

Centrepoint Alliance (ASX:CAF)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Centrepoint Alliance Limited, with a market cap of A$64.64 million, provides financial services in Australia through its subsidiaries.

Operations: The company's revenue is primarily derived from Licensee and Advice Services (A$285.39 million), supplemented by Consulting Services (A$1.25 million) and Funds Management and Administration (A$1.99 million).

Market Cap: A$64.64M

Centrepoint Alliance Limited, with a market cap of A$64.64 million, has shown promising financial metrics for a penny stock. The company is trading significantly below its estimated fair value and maintains high return on equity at 23.3%. Its short-term assets exceed both short and long-term liabilities, indicating solid liquidity management. Despite an unstable dividend track record, Centrepoint's earnings have grown by 22.5% over the past year, surpassing industry averages. The company is actively seeking acquisitions to bolster growth further while maintaining more cash than debt and ensuring strong interest coverage from profits. However, the board's inexperience could be a concern for some investors.

• Unlock comprehensive insights into our analysis of Centrepoint Alliance stock in this financial health report.
• Examine Centrepoint Alliance's past performance report to understand how it has performed in prior years.

MaxiPARTS (ASX:MXI)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: MaxiPARTS Limited, with a market cap of A$107.31 million, distributes and sells commercial truck and trailer parts in Australia through its subsidiaries.

Operations: The company generates revenue of A$243.88 million from its Maxiparts segment, which involves the distribution and sale of commercial truck and trailer parts in Australia.

Market Cap: A$107.31M

MaxiPARTS Limited, with a market cap of A$107.31 million, presents a mixed picture as an investment opportunity. The company trades significantly below its estimated fair value and has not diluted shareholders recently, which may appeal to value-focused investors. Its financial health is supported by short-term assets exceeding both short and long-term liabilities and satisfactory debt levels covered well by cash flow. However, recent negative earnings growth and declining profit margins raise concerns about profitability trends. While the management team is experienced, the board's relative inexperience might be a consideration for potential investors evaluating governance stability.

• Jump into the full analysis health report here for a deeper understanding of MaxiPARTS.
• Explore MaxiPARTS' analyst forecasts in our growth report.

Spheria Emerging Companies (ASX:SEC)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Spheria Emerging Companies Limited is an Australian investment company with a market capitalization of A$140.52 million.

Operations: The company generates revenue primarily through investment activities, amounting to A$12.09 million.

Market Cap: A$140.52M

Spheria Emerging Companies Limited, with a market capitalization of A$140.52 million, offers a complex investment landscape. The company trades slightly below its estimated fair value and has not diluted shareholders recently, which could attract value investors. Its financial position is robust with short-term assets surpassing both short and long-term liabilities, and it remains debt-free for the past five years. Despite high-quality earnings, the company faces challenges with declining profits over the past five years and negative earnings growth in the last year. Additionally, dividends may not be well-covered by earnings despite recent affirmations of payouts.

• Navigate through the intricacies of Spheria Emerging Companies with our comprehensive balance sheet health report here.
• Gain insights into Spheria Emerging Companies' historical outcomes by reviewing our past performance report.

Taking Advantage

• Investigate our full lineup of 1,026 ASX Penny Stocks right here.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com